Hiv Study
-
{
- All
- News
- Videos
-
HIV Study: Boosting Immune Cells May Help Fight Infection
Scientists are tweaking a powerful cancer therapy in hopes it could fight HIV instead, by supercharging patients' own immune cells.
-
EU Regulator Approves Twice-Yearly Injectable Drug For HIV Prevention
The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing HIV, which scientists say could help end the virus' transmission.
-
Donald Trump's Foreign Aid Cut Risks Causing 14 Million Deaths: Study
More than 14 million of the world's most vulnerable people, a third of them small children, could die by 2030 because of the Trump administration's dismantling of US foreign aid, research projected on Tuesday.
-
Anti-HIV Injection Taken Twice A Year Shows 100% Efficacy: Study
The most common adverse effects were injection-site reactions experienced by close to 70 per cent of the participants in the Lenacapavir group.
-
Injection Twice A Year 100% Effective In HIV Treatment: Study
A large clinical trial in South Africa and Uganda has shown that a twice-yearly injection of a new pre-exposure prophylaxis drug gives young women total protection from HIV infection.
-
Tesamorelin Peptide: Studies In HIV And Nerve Damage
Tesamorelin is a synthetic version of growth hormone-releasing hormone (GHRH) which has been studied to potentially increase the production and secretion of growth hormone (GH) endogenously in the organism.
-
Man Becomes 3rd Patient To Be Cured Of HIV After Stem Cell Transplant
Known as the Dusseldorf Patient, the man is only the third person in the world to be cured of the condition using stem cell transplant.
-
HIV+ Man With Cancer Cured Of Both After Stem Cell Therapy, Claims Study
A man known as "the Duesseldorf patient" has become the third person declared cured of HIV after receiving a stem cell transplant that also treated his leukaemia, a study said on Monday.
-
Early-Stage HIV Vaccine Shows Positive Results In Human Trials: Study
In a phase 1 research, 97% of patients had immune system activity in response to the vaccine.
-
Covid-Infected HIV Patient Developed 21 Mutations, Study Shows
A South African woman suffering from inadequately treated HIV, and who harbored Covid-19 for nine months saw the respiratory virus develop at least 21 mutations while in her body, according to a study.
-
HIV Treatment Has No Benefit For Hospitalised COVID-19 Patients: Study
A combination of antiviral drugs usually used to treat HIV has no beneficial effect in patients hospitalised with COVID-19, a peer-reviewed study said on Monday, confirming the initial results of a large-scale randomised trial of the drug.
-
AIDS Drugs Prevent Sexual Transmission Of HIV In Gay Men
A European study of nearly 1,000 gay male couples who had sex without condoms - where one partner had HIV and was taking antiretroviral drugs to suppress it - has found the treatment can prevent sexual transmission of the virus.
-
A Blue Pill Is Stopping HIV, World-First Study Shows
An antiviral pill led to a globally unprecedented reduction in new HIV cases, showing that a targeted, preventative approach may accelerate progress on ending the AIDS epidemic.
-
Newborn Contracts HIV Infection From Father: Study
In a rare case, researchers have found that a newborn baby contracted human immunodeficiency virus (HIV) from his father after coming into contact with the fluid leaking from a lesion on his skin.
-
HIV On The Rise In Europe, Affects One In Six People Above 50 Years Of Age
A study conducted by researchers in the European Centre for Disease Prevention and Control (ECDC) showed a steady rise in the number of cases of HIV in older age people of Europe. One in six people above 50 years of age diagnosed with the same.
-
HIV Study: Boosting Immune Cells May Help Fight Infection
Scientists are tweaking a powerful cancer therapy in hopes it could fight HIV instead, by supercharging patients' own immune cells.
-
EU Regulator Approves Twice-Yearly Injectable Drug For HIV Prevention
The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing HIV, which scientists say could help end the virus' transmission.
-
Donald Trump's Foreign Aid Cut Risks Causing 14 Million Deaths: Study
More than 14 million of the world's most vulnerable people, a third of them small children, could die by 2030 because of the Trump administration's dismantling of US foreign aid, research projected on Tuesday.
-
Anti-HIV Injection Taken Twice A Year Shows 100% Efficacy: Study
The most common adverse effects were injection-site reactions experienced by close to 70 per cent of the participants in the Lenacapavir group.
-
Injection Twice A Year 100% Effective In HIV Treatment: Study
A large clinical trial in South Africa and Uganda has shown that a twice-yearly injection of a new pre-exposure prophylaxis drug gives young women total protection from HIV infection.
-
Tesamorelin Peptide: Studies In HIV And Nerve Damage
Tesamorelin is a synthetic version of growth hormone-releasing hormone (GHRH) which has been studied to potentially increase the production and secretion of growth hormone (GH) endogenously in the organism.
-
Man Becomes 3rd Patient To Be Cured Of HIV After Stem Cell Transplant
Known as the Dusseldorf Patient, the man is only the third person in the world to be cured of the condition using stem cell transplant.
-
HIV+ Man With Cancer Cured Of Both After Stem Cell Therapy, Claims Study
A man known as "the Duesseldorf patient" has become the third person declared cured of HIV after receiving a stem cell transplant that also treated his leukaemia, a study said on Monday.
-
Early-Stage HIV Vaccine Shows Positive Results In Human Trials: Study
In a phase 1 research, 97% of patients had immune system activity in response to the vaccine.
-
Covid-Infected HIV Patient Developed 21 Mutations, Study Shows
A South African woman suffering from inadequately treated HIV, and who harbored Covid-19 for nine months saw the respiratory virus develop at least 21 mutations while in her body, according to a study.
-
HIV Treatment Has No Benefit For Hospitalised COVID-19 Patients: Study
A combination of antiviral drugs usually used to treat HIV has no beneficial effect in patients hospitalised with COVID-19, a peer-reviewed study said on Monday, confirming the initial results of a large-scale randomised trial of the drug.
-
AIDS Drugs Prevent Sexual Transmission Of HIV In Gay Men
A European study of nearly 1,000 gay male couples who had sex without condoms - where one partner had HIV and was taking antiretroviral drugs to suppress it - has found the treatment can prevent sexual transmission of the virus.
-
A Blue Pill Is Stopping HIV, World-First Study Shows
An antiviral pill led to a globally unprecedented reduction in new HIV cases, showing that a targeted, preventative approach may accelerate progress on ending the AIDS epidemic.
-
Newborn Contracts HIV Infection From Father: Study
In a rare case, researchers have found that a newborn baby contracted human immunodeficiency virus (HIV) from his father after coming into contact with the fluid leaking from a lesion on his skin.
-
HIV On The Rise In Europe, Affects One In Six People Above 50 Years Of Age
A study conducted by researchers in the European Centre for Disease Prevention and Control (ECDC) showed a steady rise in the number of cases of HIV in older age people of Europe. One in six people above 50 years of age diagnosed with the same.
